Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer

Clinical trial NCT04555837 · COMPLETED

Trial details

NCT number: NCT04555837
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Malignant Solid Neoplasm

Start date: 2020-09-15
Primary completion: 2025-04-08
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.